Preview

Лечащий Врач

Расширенный поиск

Ожирение, антибиотики и кишечная микробиота — какова связь?

Полный текст:

Аннотация

Ожирение прогрессирует в ряде стран мира со скоростью настоящей эпидемии. Новые эпидемиологические исследования показали, что воздействие антибиотиков связано с повышенным риском набора избыточного веса и ожирения. Нарушения микрофлоры кишечника происходят не только из-за лечения антибиотиками. Антибиотики широко используются в качестве стимуляторов роста в сельском хозяйстве, они накапливаются в мясе животных и птицы, которые мы употребляем в пищу. Пробиотики являются агентами, способными модулировать и улучшать кишечную микрофлору при антибиотикотерапии.

Об авторах

Е. Ю. Плотникова
ФГБОУ ВО КемГМУ МЗ РФ
Россия


О. А. Краснов
ФГБОУ ВО КемГМУ МЗ РФ
Россия


Список литературы

1. Ng M., Fleming T., Robinson M. et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis // Lancet (London, England). 2014; 384 (9945): 766–781.

2. Collaboration NCDRF. Trends in adult body?mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants // Lancet. 2016; 387 (10026): 1377–1396.

3. NCD Risk Factor Collaboration (NCD-RisC): Mariachiara Di Cesare, James Bentham, Gretchen A. Stevens, Bin Zhou, Goodarz Danaei, Yuan Lu, Honor Bixby, Melanie J. Cowan, Leanne M. Riley, Kaveh Hajifathalian, L?a Fortunato, Cristina Taddei, James E. Bennett, Nayu Ikeda, Young Ho Khang, Catherine Kyobutungi, Avula Laxmaiah, Yanping Li, Hsien Ho Lin & 31 others. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants // Lancet. 2016 Apr 2; 387 (10026): 1377–1396.

4. DeSalle R., Perkins S. L., Wynne P. J. Welcome to the Microbiome: Getting to Know the Trillions of Bacteria and Other Microbes In, On, and Around You. 2015. Yale University Press: New Haven, 264 p.

5. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism // Nature. 2012; 489 (7415): 242–249.

6. Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I. Obesity alters gut microbial ecology // Proc Natl Acad Sci USA. 2005; 102 (31): 11070–11075.

7. Плотникова Е. Ю., Краснов О. А. Метаболический синдром и кишечная микрофлора; что общего? // Экспериментальная и клиническая гастроэнтерология. 2015; 112 (12): 64–73.

8. Nieuwdorp M., Gilijamse P. W., Pai N., Kaplan L. M. Role of the microbiome in energy regulation and metabolism // Gastroenterology. 2014; 146 (6): 1525–1533.

9. Cani P. D., Lecourt E., Dewulf E. M. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal // Am J Clin Nutr. 2009; 90 (5): 1236–1243.

10. Sayin S. I., Wahlstrom A., Felin J. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro?beta?muricholic acid, a naturally occurring FXR antagonist // Cell Metab. 2013; 17 (2): 225–235.

11. Watanabe M., Morimoto K., Houten S. M. et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure // PLoS One. 2012; 7 (8): e38286.

12. Гриневич В. Б., Сас Е. И. Физиологические эффекты желчных кислот // РМЖ «Медицинское обозрение». 2017; 2: 87–91.

13. Alcock J., Maley C. C., Aktipis C. A. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms // Bioessays. 2014; 36 (10): 940–949.

14. Blaser, Martin J. Missing microbes: How the overuse of antibiotics is fueling our modern plagues. Henry Holt and Company, LLC, New York, NY, USA, 2014. 288 р.

15. Cho I., Yamanishi S., Cox L., Methe B. A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity // Nature. 2012; 488: 621–626.

16. Dominguez-Bello M. G., Blaser M. J., Ley R. E., Knight R. Development of the Human Gastrointestinal Microbiota and Insights From High-Throughput Sequencing // Gastroenterology. 2011; 140: 1713–1719.

17. Blaser M. J., Falkow S. What are the consequences of the disappearing human microbiota? // Nat Rev Micro. 2009; 7: 887–894.

18. Trasande L., Blustein J., Liu M., Corwin E., Cox L. M., Blaser M. J. Infant antibiotic exposures and early-life body mass // Int J Obes. 2013; 37: 16–23.

19. Blustein J. et al. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years // Int J Obes. 2013; 37: 900–906.

20. Huh S. Y., Rifas-Shiman S. L., Zera C. A., Edwards J. W. R., Oken E., Weiss S. T., Gillman M. W. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study // Arch Dis Childhood. 2012; 97: 610–616.

21. Coates M. E., Fuller R., Harrison G. F., Lev M., Suffolk S. F. A comparison of the growth of chicks in the Gustafsson germ-free apparatus and in a conventional environment, with and without dietary supplements of penicillin // Br J Nutr. 1963; 17: 141–150.

22. Dethlefsen L., Huse S., Sogin M. L., Relman D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing // PLoS Biol. 2008; 6: e280.

23. Dethlefsen L., McFall-Ngai M., Relman D. A. An ecological and evolutionary perspective on human-microbe mutualism and disease // Nature. 2007; 449: 811–818.

24. Sullivan A., Edlund C., Nord C. E. Effect of antimicrobial agents on the ecological balance of human microflora // Lancet Infect Dis. 2001; 1: 101–114.

25. Beaugerie L., Petit J. C. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea // Best Pract Res Clin Gastroenterol. 2004; 18: 337–352.

26. Wilcox M. H. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis // Best Pract Res Clin Gastroenterol. 2003; 17: 475–493.

27. Marra F., Lynd L., Coombes M., Richardson K., Legal M. et al. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis // Chest. 2006; 129: 610–618.

28. Noverr M. C., Huffnagle G. B. The ‘microflora hypothesis’ of allergic diseases // Clin Exp Allergy. 2005; 35: 1511–1520.

29. Prioult G., Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation // Immunol Rev. 2005; 206: 204–218.

30. Nicholson J. K., Holmes E., Wilson I. D. Gut microorganisms, mammalian metabolism and personalized health care // Nat Rev Microbiol. 2005; 3: 431–438.

31. O’Keefe S. J., Chung D., Mahmoud N., Sepulveda A. R., Manafe M. et al. Why do African Americans get more colon cancer than Native Africans // J Nutr. 2007; 137: 175S-182S.

32. McGarr S. E., Ridlon J. M., Hylemon P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature // J Clin Gastroenterol. 2005; 39: 98–109.

33. Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D. et al. Obesity alters gut microbial ecology // Proc Natl Acad Sci USA. 2005; 102: 11070–11075.

34. B?ckhed F., Ding H., Wang T., Hooper L. V., Koh G. Y. et al. The gut microbiota as an environmental factor that regulates fat storage // Proc Natl Acad Sci USA. 2004; 101: 15718–15723.

35. Stewart C. S., Duncan S. H., Cave D. R. Oxalobacter formigenes and its role in oxalate metabolism in the human gut // FEMS Microbiol Lett. 2004; 230: 1–7.

36. Lofmark S., Jernberg C., Billstrom H., Andersson D. I., Edlund C. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine // Anaerobe. 2008; 14: 157–160.

37. Sjolund M., Wreiber K., Andersson D. I., Blaser M. J., Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori // Ann Intern Med. 2003; 139: 483–487.

38. B?ckhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. Host-bacterial mutualism in the human intestine // Science. 2005; 307: 1915–1920.

39. Parikh N. I., Pencina M. J., Wang T. J., Lanier K. J., Fox C. S., D’Agostino R. B., Vasan R. S. Increasing trends in incidence of overweight and obesity over 5 decades // Am J Med. 2007 Mar; 120 (3): 242–250.

40. Nestle, Marion. Food Politics: How the Food Industry Influences Nutrition and Health. Berkeley: U of California, 2002. 457 р.

41. Eric Andrew Finkelstein, Wan Chen Kang Graham, Rahul Malhotra. Lifetime Direct Medical Costs of Childhood Obesity // Pediatrics. 2014, April. 133: 1–9.

42. Hayes A., Chevalier A., D’Souza M., Baur L., Li Ming Wen, Judy Simpson. Early childhood obesity: Association with healthcare expenditure in Australia // Obesity. 2016; 24 (8): 1752–1758.

43. Moriarty J. P., Branda M. E., Olsen K. D., Shah N. D., Borah B. J., Wagie A. E., Egginton J. S., Naessens J. M. The Effects of Incremental Costs of Smoking and Obesity on Health Care Costs Among Adults // Journal of Occupational and Environmental Medicine, 2012; 54 (3): 286.

44. Broe A., Potteg?rd A., Lamont R. F., J?rgensen J. S., Damkier P. Increasing use of antibiotics in pregnancy during the period 2000–2010: prevalence, timing, category, and demographics // BJOG. 2014; 121: 988–996.

45. Vidal A. C. et al. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring // Int J Obes. 2013; 37: 907–913.

46. Jepsen P. et al. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark // British Journal Of Clinical Pharmacology. 2003; 55: 216–221.

47. Hicks L. A., Taylor T. H., Hunkler R. J. U. S. Outpatient Antibiotic Prescribing, 2010 // New Engl J Med. 2013; 368: 1461–1462.

48. McCaig L. F., Besser R. E., Hughes J. M. Trends in antimicrobial prescribing rates for children and adolescents // JAMA: The Journal of the American Medical Association. 2002; 287: 3096–3102.

49. Grijalva C. G., Nuorti J., Griffin M. R. Antibiotic prescription rates for acute respiratory tract infections in us ambulatory settings // JAMA. 2009; 302: 758–766.

50. Слайд-шоу из лекции «Антибиотики и ожирение» Blaser M. J. https://www.amnh.org/explore/science-topics/health-and-our-microbiome/meet-your-microbiome.

51. Ternhag A, Hellman J. More on U. S. Outpatient Antibiotic Prescribing, 2010 // New Engl J Med. 2013; 369: 1175–1176.

52. Hersh A. L., Jackson M. A., Hicks L. A. DISEASES, t.C.O.I. Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics // Pediatrics. 2013; 132: 1146–1154.

53. Fridkin S. et al. Vital signs: improving antibiotic use among hospitalized patients // MMWR. Morbidity and mortality weekly report. 2014; 63: 194–200.

54. Lee G. C. et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010 // BMC medicine. 2014; 12: 96.

55. Gerber J. S. et al. Variation in Antibiotic Prescribing Across a Pediatric Primary Care Network // J Pediatric Infect Dis Soc. 2014. In press, DOI: 10.1093/jpids/piu086.

56. Ajslev T. A., Andersen C. S., Gamborg M., S?rensen T. I. A., Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics // Int J Obes. 2011; 35: 522–529.

57. Azad M. B., Bridgman S. L., Becker A. B., Kozyrskyj A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity // Int J Obes. 2014: 1–9.

58. Bailey L. C. et al. Association of Antibiotics in Infancy With Early Childhood Obesity // JAMA Pediatr. 2014; 168 (11): 1063–1069.

59. Murphy R. et al. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study // Int J Obes. 2013; 38: 115–119.

60. Cox L. M., Blaser M. J. Antibiotics in early life and obesity // Nat Rev Endocrinol. 2015, Mar; 11 (3): 182–190.

61. Hooper L. V., Littman D. R., Macpherson A. J. Interactions between the microbiota and the immune system // Science. 2012; 336: 1268–1273.

62. Mueller N. T., Whyatt R., Hoepner L., Oberfield S., Dominguez-Bello M. G., Widen E. M., Hassoun A., Perera F., Rundle A. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity // Int J Obes (Lond). 2015, Apr; 39 (4): 665–670.

63. Dethlefsen L., Relman D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation // Proc Natl Acad Sci USA. 2011, 108 (Suppl 1): 4554–6110.

64. Thuny F., Richet H., Casalta J.-P., Angelakis E., Habib G., Raoult D. Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity // PLoS One. 2010; 5 (2): e9074.

65. Jakobsson H. E., Jernberg C., Andersson A. F., Sjolund-Karlsson M., Jansson J. K., Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome // PLoS One. 2010; 5: e9836.

66. Jernberg C., Lofmark S., Edlund C., Jansson J. K. Long-term impacts of antibiotic exposure on the human intestinal microbiota // Microbiology. 2010; 156: 3216–3223.

67. Jess T. Microbiota, antibiotics, and obesity // N Engl J Med. 2014; 371: 2526–2528.

68. Riley L. W., Raphael E., Faerstein E. Obesity in the United States — dysbiosis from exposure to low-dose antibiotics? // Front Public Health. 2013; 1: 69.

69. Alang N., Kelly C. R. Weight gain after fecal microbiota transplantation // Send to Open Forum Infect Dis. 2015, Feb 4; 2 (1): ofv004.

70. Vrieze A., Van Nood E., Holleman F., Saloj?rvi J., Kootte R. S., Bartelsman J. F., Dallinga-Thie G. M., Ackermans M. T., Serlie M. J., Oozeer R., Derrien M., Druesne A., van Hylckama Vlieg J. E., Bloks V. W., Groen A. K., Heilig H. G., Zoetendal E. G., Stroes E. S., de Vos W. M., Hoekstra J. B., Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome // Gastroenterology. 2012, Oct; 143 (4): 913–6.e7.

71. Feighner S. D., Dashkevicz M. P. Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity // Appl Environ Microbiol. 1987; 53: 331–336.

72. Backhed F., Ding H., Wang T., Hooper L. V., Koh G. Y. et al. The gut microbiota as an environmental factor that regulates fat storage // Proc Natl Acad Sci USA. 2004; 101: 15718–15723.

73. Andrade M. J., Jayaprakash C., Bhat S., Evangelatos N., Brand A., Satyamoorthy K. Antibiotics-Induced Obesity: A Mitochondrial Perspective // Public Health Genomics. 2017; 20: 257–273.

74. Angelakis E. Weight gain by gut microbiota manipulation in productive animals // Microb Pathog. 2017, May; 106: 162–170.

75. Acar J., Casewell M., Freeman J., Friis C., Goossens H. Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making // Clin Microbiol Infect. 2000; 6: 477–482.

76. Dyer I. A., Koes R. M., Herlugson M. L., Ojikutu L. B., Preston R. L. et al. Effect of avoparcin and monensin on performance of finishing heifers // J Anim Sci. 1980; 51: 843–846.

77. Война миров: антибиотики в сельском хозяйстве. На сайте The DairyNews http://www.dairynews.ru/dairyfarm/voyna-mirov-antibiotiki-v-selskom-khozyaystve.html.

78. Marshall B. M., Levy S. B. Food Animals and Antimicrobials: Impacts on Human Health // Clin Microbiol Rev. 2011; 24: 718–733.

79. Donoghue D. J. Antibiotic residues in poultry tissues and eggs: human health concerns? // Poultry Sci. 2003; 82: 618–621.

80. Ternak G. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? // Medical Hypotheses. 2005; 64: 14–16.

81. Riley L. W. Obesity in the United States — dysbiosis from exposure to low-dose antibiotics? 2013: 1–8.

82. Taylor J. H., Gordon W. S. Growth-promoting activity for pigs of inactivated penicillin // Nature. 1955; 176: 312–313.

83. Jukes T. H., Williams W. L. Nutritional effects of antibiotics // Pharmacol Rev. 1953; 5: 381–420.

84. Gaskins H., Collier C., Anderson D. Antibiotics as growth promotants: mode of action // Anim Biotechnol. 2002; 13: 29–42.

85. Butaye P., Devriese L., Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria // Clin Microbiol Rev. 2003; 16: 175–188.

86. Van Boeckel T. P., Brower C., Gilbert M., Grenfell B. T., Levin S. A., Robinson T. P., Teillant A., Laxminarayan R. Global trends in antimicrobial use in food animals // PNAS. 2015. March 19, 201503141. http://www.pnas.org/content/pnas/early/2015/03/18/1503141112.full.pdf.

87. Muir L. A. Mode of action of exogenous substances on animal growth — an overview // Journal of animal science. 1985; 61: 154–180.

88. Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G. Richness of human gut microbiome correlates with metabolic markers // Nature. 2013; 500.

89. Cotillard A., Kennedy S. P., Kong L. C. et al. Dietary intervention impact on gut microbial gene richness // Nature. 2013; 500 (7464): 585–588.

90. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I. An obesity?associated gut microbiome with increased capacity for energy harvest // Nature 2006; 444 (7122): 1027–1031.

91. Mingqian He, Bingyin Shi. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics // Cell Biosci. 2017; 7: 54.

92. Sanders M. E. Probiotics and microbiota composition // BMC Med. 2016; 14 (1): 82.

93. Eloe-Fadrosh E. A., Brady A., Crabtree J. et al. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio 2015; 6(2): 1–12.

94. McNulty N. P., Yatsunenko T., Hsiao A. et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins // Sci Transl Med. 2011; 3 (106): 106ra.

95. Drissi F., Raoult D., Merhej V. Metabolic role of lactobacilli in weight modification in humans and animals // Microb Pathog. 2016; 106: 182–194.

96. Zhang Q., Wu Y., Fei X. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trials // Int J Food Sci Nutr. 2015; 67 (5): 571–580.

97. Borgeraas H., Johnson L. K., Skattebu J., Hertel J. K., Hjelmes?th J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials // Obes Rev. 2018 Feb; 19 (2): 219–232.

98. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., Okano M., Kagoshima M., Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial // Eur J Clin Nutr. 2010; 64 (6): 636–643.


Рецензия

Для цитирования:


Плотникова Е.Ю., Краснов О.А. Ожирение, антибиотики и кишечная микробиота — какова связь? Лечащий Врач. 2019;(3):84.

For citation:


Plotnikova E.Yu., Krasnov O.A. Obesity, antibiotics and intestinal microbiota — how are they connected? Lechaschi Vrach. 2019;(3):84. (In Russ.)

Просмотров: 53


Creative Commons License
Контент доступен под лицензией Attribution-NonCommercial-NoDerivatives 4.0 International.


ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)